LncRNA HEIH Enhances Paclitaxel-Tolerance of Endometrial Cancer Cells via Activation of MAPK Signaling Pathway

Investigation of the potential theranostic role of KDM5B/miR-29c signaling axis in paclitaxel resistant endometrial carcinoma

(2019) Lijie Li et al.   GENE

Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinoma

(2018) Sulsal-Ul Haque et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Long Noncoding RNA HEIH Promotes Colorectal Cancer Tumorigenesis via Counteracting miR-939‒Mediated Transcriptional Repression of Bcl-xL

(2018) Chunhui Cui et al.   Cancer Research and Treatment

Overexpression of the lncRNA FER1L4 inhibits paclitaxel tolerance of ovarian cancer cells via the regulation of the MAPK signaling pathway

(2018) Siwei Liu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study

(2017) Henry D. Reyes et al.   GYNECOLOGIC ONCOLOGY

Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancer

(2017) Niamh McGivern et al.   Oncotarget

LncRNA SNHG12 contributes to multidrug resistance through activating the MAPK/Slug pathway by sponging miR-181a in non-small cell lung cancer

(2017) Pei Wang et al.   Oncotarget

lncRNAs and microRNAs with a role in cancer development

(2016) Julia Liz et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Identification of Long Non‐Coding RNAs Deregulated in Multiple Myeloma Cells Resistant to Proteasome Inhibitors

(2016) Ehsan Malek et al.   Genes

NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer

(2015) Akila N. Viswanathan et al.   CANCER

Non-coding RNA in control of gene regulatory programs in cardiac development and disease

(2015) Leonne E. Philippen et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins

(2015) Lixia Bai et al.   MEDICAL ONCOLOGY

Non-coding RNA in neural function, disease, and aging

(2015) Kirk Szafranski   Frontiers in Genetics

Integrative Analysis of Normal Long Intergenic Non-Coding RNAs in Prostate Cancer

(2015) Pushpinder Bawa et al.   PLoS One

Long noncoding RNAs: Novel insights into hepatocelluar carcinoma

(2013) Yong He et al.   CANCER LETTERS

Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers

(2013) Budiman Kharma et al.   INTERNATIONAL JOURNAL OF CANCER

The Long Noncoding RNA HOTAIR Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma Cells via downregualtion of p21WAF1/CIP1 Expression

(2013) Zhili Liu et al.   PLoS One

Differential sensitivity to paclitaxel-induced apoptosis and growth suppression in paclitaxel-resistant cell lines established from HEC-1 human endometrial adenocarcinoma cells

(2012) TETSUJI TANAKA et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression

(2012) Lingling Dong et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans

(2011) Fu Yang et al.   HEPATOLOGY

The Potential and Limitations of p38MAPK as a Drug Target for the Treatment of Hematological Malignancies

(2010) Shivashni S. Gaundar et al.   CURRENT DRUG TARGETS

Emerging drugs in endometrial cancers

(2010) Ozden Altundag et al.   EXPERT OPINION ON EMERGING DRUGS

Systematic review to establish the safety profiles for direct and indirect inhibitors of p38 Mitogen-activated protein kinases for treatment of cancer

(2008) J. Kay Noel et al.   MEDICAL ONCOLOGY